One of the most dynamic changes in U.S. healthcare is the growth and proliferation of Integrated Delivery Networks. Here we review how IDNs originated and common characteristics major networks share.
Over the past several years, the push by providers and payers toward higher quality, lower cost care has gained momentum. Policy, increased incentives, buying behaviors and other factors have prompted regional health networks to offer care in a more coordinated setting, fundamentally changing how the delivery of health is provided and managed. These changes make this one of the most dynamic eras in the evolution of U.S. healthcare.
Of these changes, one of the most noticeable is the growth and proliferation of Integrated Delivery Networks, or IDNs. An IDN is set of physicians working with hospitals to form a healthcare ecosystem where a person can receive any type of care it needs from one single ‘brand’ of healthcare provider. Ultimately, the goal is holistic care; as a patient, you can receive preventable care, physical therapy and everything in between. Through electronic health records (EHRs) patient information can be stored, tracked and shared within the network providing comprehensive view of a patient’s health.
How are IDNs transforming the healthcare landscape?
“Every market in the nation is coalescing around a handful of healthcare ecosystems. IDNs are the cornerstones of these ecosystems.”
IDNs come in all shapes in sizes. Some can be a collection of hospitals or focus on a specific therapy area. Through acquisitions and mergers, major IDNs have come to dominate major markets to create a truly holistic source of healthcare by offering a true continuum of care. In doing so, these major IDNs can exert a lot of leverage among their physician groups as well as with payers and can even blur the lines between provider and payer as they grow and leverage their influence. For instance, they can create collaborative plans with payers but can also work directly with employers to provide healthcare plans via their own formularies, protocols and reimbursement processes.
How did IDNs get started?
The Affordable Care Act helped to accelerate the formation of integrated delivery networks due to the emphasis placed on accountable care and clinical integration. Hospitals had to learn to adapt as Accountable Care Organizations (ACOs) started to form due to the shift from volume to value in healthcare delivery. As ACOs focused on contracting between payers and providers to help control costs and ultimately keep patients out of hospitals, these hospital-based groups began to adjust their business models to help control patient populations and offer holistic care.
IDNs began to emerge as hospitals began leveraging their capital and regional branding to naturally evolve into these large networks and use ACOs as part of their “toolbox” to deliver care. Some of the earliest IDNs include Kaiser Permanente, University of Pittsburgh Medical Center and Baylor Scott & White Health (an HMO-style IDN).
What do the most prominent IDNs have in common?
Although there are many attributes to consider when identifying an IDN, there are five main criteria that major IDNs share:
Provider alignment development stage and physician data
This is really the DNA of an IDN. Within these systems, large IDNs have centralized control of physicians through employment and/or clinical integration, and common branding across facilities in the region.
Continuum of care
Essentially, large IDNs are able to offer more services, from preventative care and primary/urgent level care to post-acute care and various therapies and treatments. If there is a large breadth of services, there is more patient containment.
Large IDNs can efficiently communicate within an established and unified EHR system which is shared and actively monitored to gauge protocol adherence and patient outcomes. The largest IDNs will often have their own formularies.
IDNs that cater to the broadest set of patient needs typically control large portions of the market. They can use this as leverage when negotiating with payers and drug manufacturers as a way to further drive down cost.
In increasing numbers, large IDNs have contracts where they accept some sort of risk with payers to push for better patient outcomes. They can also influence physician and patient behavior by pushing specific protocols and treatments.
Navigate and build relationships with IDNs
Life science companies can rely on the strength of Clarivate healthcare affiliations data and market analysis to understand IDN control, enhance their market access strategy and optimize their sales force, all within a single intuitive platform:
- Gain a deep understanding of provider and vertically integrated healthcare systems, from the macro-level down to the individual physician-level, to properly align home office strategy and field force teams.
- Gauge the rising influence of IDNs within local markets and address them in an effective way.
- Engage your most significant customer groups efficiently and intelligently with specific data on the strength of their affiliations.
Healthbase has been built to provide multi-disciplinary market access teams with the data and insight they need to understand alignments between systems – down to the individual provider level – and ascertain the market control of IDNs across U.S. regions and patient populations.
- Measure current and accurate strengths of relationships between physicians and IDNs.
- Map payer shares for individual IDNs within a market.
- Understand with deeper insights by accessing an expansive trove of claims data that accurately reports percentage of patients by therapy area.
- Effectively segment IDNs and inform engagement strategies for specific therapy areas.